Vault-13

REGENERON PHARMACEUTICALS, INC.

TARRYTOWN, NY · CIK 872589 · 13F filing filed 2026-08-07

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$177.2m reported value +270.1% vs Q1 2026
3positions
100.0%in top 10
2 new 0 added 0 reduced 1 sold out vs Q1 2026

Holdings, Q2 2026

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 PARABILIS MEDICINES INC COM PBLS PBLS 4,166,666 $114.0m64.35% 64.35% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 4.2m
2 INTELLIA THERAPEUTICS INC COM NTLA NTLA 3,702,995 $62.7m35.35% 35.35% UnchangedShares held: Q3 2025 3.7m, Q4 2025 3.7m, Q1 2026 3.7m, Q2 2026 3.7m
3 ADICET BIO INC COM NEW ACET ACET 60,511 $522.8k0.30% 0.30% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 60.5k

Sold out since Q1 2026

SecurityTickerShares held beforeValue then
ADICET BIO INC 60,511 $412.1k60.5k shares